. For influenza virus, only amantadine and its derivatives have been shown unequivocally to be useful in preventing influenza in man. The parent compound, a cyclic primary amine, 1-aminoadamantane hydrochloride (amantadine or Symmetrel) was discovered in the early 1960s (Davies et al., 1964) . Amantadine ( Fig.; 1) is used at present on a rather limited scale in England, Europe, and the U.S.A. Its efficacy has been reviewed by Galbraith and Watson, (1977) and Sabin (1978) . A derivative, a-methyl-1-adamantanemethylamine, or rimantadine, is being used more widely in the U.S.S.R. as a therapeutic agent (Blyuger et al., 1970; Smorodintsev et al., 1970) against influenza. Since amantadine is the first, clinically useful inhibitor of influenza A virus much can be learnt from a study of the mode of action of the compound. A nucleoside analogue, Ribavirin (Sidwell et al., 1972; reviewed by Oxford, 1975) has been shown to have mild prophylactic activity for influenza in man but may be unacceptably toxic ( Fig. 1) (Oxford, 1977; Jackson, 1977 (Simpson and Hirst, 1968 (Oxford, Logan and Potter, 1970) (Bangham, Standish and Watkins, 1965; Gregoriadis 1964; Ryman, 1974 (Chow and Simpson, 1971; Skehel, 1971; Oxford, 1973) . In addition, RNA-polymerase activity has been detected in the microsomes (Scholtissek, 1970) and nuclei (Mahy, 1970) (Oxford, 1973) . The author and his colleagues have described the in vitro inhibition of influenza virus-associated RNA-dependent RNA polymerase by selenocystamine dihydrochloride, bathophenanthroline disodium disulphonate and certain heterocyclic thiosemicarbazones (Fig. 2b) . A property common to these compounds is the ability to chelate soft, heavy, metal ions such as zinc and copper. Con- versely, similar types of compounds in which the possibility of chelation was diminished showed significantly less inhibitory activity against influenza virus RNA-dependent RNA polymerase. Mass spectrometry and atomic absorption techniques have detected the association of zinc with purified influenza B virus and the hypothesis is advanced that the RNA-dependent RNA polymerase enzyme of influenza virus is a zinc-activated enzyme or a zinc metallo-enzyme (Oxford and Perrin, 1974; Perrin, 1977) .
The RNA-dependent RNA polymerase of influenza A and B viruses was inhibited by bathophenanthroline (disodium disulphonate), and bathocuproine (Oxford and Perrin, 1977 (Oxford and Perrin, 1977 (Oxford, 1977 (Chow and Simpson, 1971 (Perrin, 1977) . These analogues were synthetized (Oxford and Perrin, 1977) Perrin, unpublished) . It was proposed, therefore, that the compounds described above inhibited the virus-associated RNA polymerase enzyme by formation of a ternary enzyme-metalligand complex (Oxford and Perrin, 1974 (Perrin, 1977 (Fig. 3) . By using encapsulation in liposomes, the deposition and tissue-retention of highly charged inhibitors may be significantly increased. In these model experiments Ca-EDTA or Ca-DPTA were used which are effective chelators of zinc but have a low and defined toxicity in experimental animals and man. The rationale of the experiments was to deplete the zinc levels in cells of the upper respiratory tract and hence to prevent the formation of, or inhibit the function of, the zinc containing influenza RNA transcriptase enzyme (Oxford and Perrin, 1977) . However, in preliminary experiments in influenza virus-infected ferrets and mice, no antiviral activity was detected with the latter compounds, although only very low concentrations have been tested to date.
In summary, therefore, it was possible to use a semi-rationale approach to selecting and then delivering to a site of action inhibitors of influenza virus. In the final event the model compounds failed to show in vivo activity against influenza viruses. However, the study was a relatively small one and similar approaches in other laboratories have since led to the selection of inhibitors of influenza RNA transcriptase with biological activity (E. Helgstrand, personal communication). Analysis of the synthesis of influenza virus-induced polypeptides and RNA As well as the application of newer enzyme and biochemical tests to screening for virus inhibitory substances these methods can be applied to establish the mode of action of existing antivirals. An understanding of the mechanism of action of present inhibitors at the molecular level would be expected to lead to synthesis of more specific and effective compounds. Few of the existing antiviral compounds including amantadine have an established mode of action.
In collaboration with S. Patterson and R. (Table 2 ). The precise point of action of amantadine appears to be after late uncoating or an unknown event accompanying this, before transcription. (Fig. 4) (Oxford, 1977) . p.f.u. = plaque-forming units; SDS = sodium dodecyl sulphate. 
Conclusions
The 'first decade' of antiviral chemotherapy (Bauer, 1973) (Skehel and Waterfield, 1975 
